Status:
UNKNOWN
Radiation Dose Reduction Using Advanced Fluoroscopy Options in Coronary Cath Lab
Lead Sponsor:
Tabba Heart Institute
Conditions:
Radiation Exposure
Coronary Artery Disease
Eligibility:
All Genders
18-100 years
Phase:
NA
Brief Summary
Fluoroscopy is integral part of diagnostic and therapeutic cardiac procedures. Among medical personnel, interventional cardiologists have the highest per head per year exposure to ionizing radiation w...
Detailed Description
Fluoroscopy is integral part of diagnostic and therapeutic cardiac procedures. Due to the ionizing effect of X-rays; patients, interventionist and cath lab staff are at risk of radiation hazards that ...
Eligibility Criteria
Inclusion
- percutaneous coronary interventional (PCI) and other fluoroscopy assisted cardiac procedures including valvular interventions and device closures.
- Both emergent and elective procedures.
- Patients undergoing procedures both via trans-radial or trans-femoral approach will be included.
Exclusion
- Intra-cardiac device insertions and procedures requiring digital subtraction angiography (DSA) will be excluded.
Key Trial Info
Start Date :
July 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 31 2021
Estimated Enrollment :
480 Patients enrolled
Trial Details
Trial ID
NCT04389190
Start Date
July 1 2020
End Date
March 31 2021
Last Update
May 15 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tabba Heart Institute
Karachi, Sindh, Pakistan, 75950